First Eagle Investment Management LLC Grows Stake in Aveanna Healthcare Holdings Inc. $AVAH

First Eagle Investment Management LLC increased its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 12.1% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 810,667 shares of the company’s stock after acquiring an additional 87,500 shares during the quarter. First Eagle Investment Management LLC’s holdings in Aveanna Healthcare were worth $4,240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of AVAH. Rhumbline Advisers boosted its position in Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock worth $410,000 after purchasing an additional 2,918 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of Aveanna Healthcare by 16.2% during the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after purchasing an additional 4,349 shares during the period. AQR Capital Management LLC increased its position in shares of Aveanna Healthcare by 21.2% during the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after purchasing an additional 4,602 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Aveanna Healthcare by 4.2% during the 1st quarter. Bank of New York Mellon Corp now owns 114,881 shares of the company’s stock valued at $623,000 after purchasing an additional 4,655 shares during the last quarter. Finally, Banque Transatlantique SA bought a new position in shares of Aveanna Healthcare in the 1st quarter worth approximately $25,000. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on AVAH. Weiss Ratings restated a “hold (c)” rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. Barclays upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Wall Street Zen upgraded Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $6.00 to $10.00 in a report on Thursday, September 18th. Finally, UBS Group lifted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday. Three equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $10.07.

Aveanna Healthcare Trading Up 1.4%

NASDAQ:AVAH opened at $8.75 on Friday. The stock has a 50-day moving average price of $8.86 and a 200 day moving average price of $6.50. The stock has a market capitalization of $1.83 billion, a P/E ratio of 24.31 and a beta of 2.04. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.67 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 103.46% and a net margin of 3.29%.The company had revenue of $450.53 million for the quarter. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the firm’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the completion of the transaction, the insider directly owned 386,284 shares of the company’s stock, valued at approximately $3,476,556. This trade represents a 96.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business’s stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $75,114,531.00. Following the completion of the sale, the insider owned 20,544,696 shares in the company, valued at approximately $184,902,264. The trade was a 28.89% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 32,597,968 shares of company stock worth $293,381,712. 7.80% of the stock is owned by insiders.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.